QUALITY AND TRANSPARENCY
Resources

Comments to Docket 2006-D-0031, Draft Informed Consent Information Sheet: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors

Public Comments

Comments provided on: September 11, 2014

Presented at: Food and Drug Administration